Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2681011000168112 | Olmesartan HCT 20/12.5 (GPPL) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2681021000168117 | Olmesartan HCT 20/12.5 (GPPL) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Olmesartan HCT 20/12.5 (GPPL) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets, blister pack (containered trade product pack) | has TPUU | True | Olmesartan HCT 20/12.5 (GPPL) tablet | Inferred relationship | Some | 1 |
Olmesartan HCT 20/12.5 (GPPL) tablet, 10 | has TPUU | True | Olmesartan HCT 20/12.5 (GPPL) tablet | Inferred relationship | Some | 1 |
Olmesartan HCT 20/12.5 (GPPL) tablet, 30 | has TPUU | True | Olmesartan HCT 20/12.5 (GPPL) tablet | Inferred relationship | Some | 1 |
Olmesartan HCT 20/12.5 (GPPL) tablet, 30, blister pack | has TPUU | True | Olmesartan HCT 20/12.5 (GPPL) tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set